Skip to main content
. 2021 Aug 24;17:2791–2802. doi: 10.2147/NDT.S292471

Figure 1.

Figure 1

MiR-101 was significantly downregulated after I/R in vitro or in vivo. (AC) The neuronal cells were exposed to OGD/R. (A) The cell viability was measured by MTT assay (n = 3). (B) The apoptotic rate was detected by flow cytometry (n = 3). (C) The mRNA level of miR-101 was evaluated by qRT-PCR (n = 3). (DG) Rats were exposed to MCAO/R. (D) Neurobehavioral outcomes (n = 6). (E) Infarct volumes (n = 6). (F and G) The mRNA level of miR-101 in brain tissues (F) and plasma (G) was evaluated by qRT-PCR (n = 6). Data were presented as mean ± SD. **p < 0.01.